General Information


DRAVP ID  DRAVPe02009

Peptide Name   Peptide 11

Sequence  TNTTT

Sequence Length  5

UniProt ID  No entry found

Source  Synthetic construct



Activity Information


Target Organism  DENV

Assay  Antiviral assays(Cell protection assay, Direct virus inhibition assay, Post-infection assay, Viral attachment assay, Viral entry assay)

Activity  [Ref.36739680]Peptides 11 at 200 μM exhibited cell protection effects below 50% against all four DENV serotypes(DENV-1, DENV-2, DENV-3, DENV-4); peptides 11 (200 μM) also showed inhibitions of all four DENV serotypes, but significantly lower inhibitions were observed against DENV-3 at 3.57%.

Hemolytic Activity  No hemolysis information or data found in the reference(s) presented in this entry

Cytotoxicity 

  • [Ref.36739680]did not exhibit any significant cytotoxic effects towards Vero cells up to 200 μM.

Binding Target  Not found

Mechanism  No machanism information found in the reference(s) presented in this entry



Structure Information


PDB ID  None

Predicted Structure Download  No predicted structure available

Linear/Cyclic  Linear

N-terminal Modification  Acetylation

C-terminal Modification  Amidation

Other Modification  None

Stereochemistry  L



Physicochemical Information


Formula  C20H36N6O11

Absent amino acids  ACDEFGHIKLMPQRSVWY

Common amino acids  T

Mass  536.54

Pl  5.19

Basic residues  0

Acidic residues  0

Hydrophobic residues  0

Net charge  0

Boman Index  -1692

Hydrophobicity  -126

Aliphatic Index  0

Half Life 

  •     Mammalian:7.2 hour
  •     Yeast:>20 hour
  •     E.coli:>10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5



Literature Information


Literature 1

Title   Development of novel antiviral peptides against dengue serotypes 1-4. 

Pubmed ID   36739680

Reference   Virology. 2023 Mar;580:10-27.

Author   Lee MF, Anasir MI, Poh CL. 

DOI   10.1016/j.virol.2023.01.016